The emerging market for COVID-19 diagnostics offers significant opportunities, especially in home and office testing solutions and adapting lab capacities post-pandemic. Innovators in saliva tests, ...
The main market opportunities in Syndromic Multiplex Diagnostics include the merging of Point of Care Testing and Molecular Diagnostics, which is streamlining frontline test protocols while reducing ...
Emerging opportunities in diagnostics include rapid and point-of-care testing, consumer markets, and biomarker development. Immunoassays are expanding due to genetic advances, with multiplex becoming ...
The rise of OTC and DTC diagnostics, driven by advancements in rapid and multiplex testing for home use, presents significant market opportunities. The shift towards consumer-accessible infectious ...
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results